The aim of this study is to determine the diagnostic accuracy of antithyroglobulin antibodies in predicting recurrent differentiated thyroid carcinoma. We searched PubMed (1990-2010) and Google Scholar (1990-2010). Citation searches, manual searches and screening of references of f included studies were done. Diagnostic studies that utilized antithyroglobulin antibodies as a predictor of recurrent differentiated thyroid carcinoma. The authors searched citations that correlated with the criteria using a data collection form generated in Review Manager 5 (REVMAN 5). The methodological quality was then assessed using Quality Assessment of Studies of Diagnostic Accuracy (QUADAS). Hierarchical summary receiver operating characteristic (HSROC) mete-analytical tool was used to estimate summary receiver operating characteristic (ROC) curves. Eight studies with 2116 participants with 182 patients with recurrent differentiated thyroid carcinoma were included. Pooled sensitivity and specifically were 63% and 79% respectively. SROC shows an overall are under the curve (AUC) of 0.712. Antithyroglobulin antibody has ability to predict recurrent differentiated thyroid carcinoma.
THYROID NEOPLASMS ; NEOPLASMS ; NEOPLASMS BY SITE ; ENDOCRINE GLAND NEOPLASMS

This is a case report of a 51-year-old female diagnosed with papillary microcarcinoma of the thyroid gland after undergoing total thyroidectomy. A 99mTc pertechnetate thyroid scan was done before radioiodine ablation therapy. It showed cervical neck lymph nodes taking up the radiotracer. Another scan after ablation therapy showed the same nodes taking up the therapeutic iodine131. The paper discusses using 99mTc pertechnetate to detect thyroid cancer metastases.
Human ; Female ; Middle Aged ; THYROID NEOPLASMS ; NEOPLASMS ; NEOPLASMS BY SITE ; ENDOCRINE GLAND NEOPLASMS

Mammography remains the mainstay of screening for primary breast cancer, however, some limitations persists in women with dense breast, in its inability to differentiate a benign from a malignant lesion, and in its heavy reliance on the radiologists' skill. Breast specific gamma imaging, which evaluates the functional images rather than anatomic images seen in mammography, addresses these limitations and can be a potential adjunct in screening for breast cancer. This meta-analysis aims to determine the diagnostic accuracy of breast specific gamma imaging for diagnosing breast cancer in women who are high risk. We searched PUBMED (1999-2009) and Google Scholar (1999-2009) for diagnostic accuracy studies that compared breast specific gamma imaging with histopathologic diagnosis of breast cancer in high risk women. Citation searches and screening of references of included studies were conducted. Two authors searched citations that correlated with the criteria using a data collection form. The methodological quality was then assessed by three authors using the QUADAS method. HSROC meta-analytical tool was used to estimate summary ROC curves. Four studies with 360 participants and 411 lesions were included. Breast specific gamma imaging has a high sensitivity (84%-97%) and specificity (60%-86%). SROC shows the included studies have high overall accuracy. Breast specific gamma imaging has high diagnostic accuracy in detecting breast cancer in women at high risk.

Human ; Female ; Breast Neoplasms ; Neoplasms ; Neoplasms By Site ; Breast ; Mammography ; Roc Curve ; Radiologists ; Sensitivity And Specificity

Placental site trophoblastic tumor (PSTT) is a rare form of gestational trophoblastic tumor (GTT) that has different behavior in disease process. The hysterectomy is general for PSTT, but hysterectomy is undesirable for patients who wish to remain fertile. We planned to preserve fertility of a young patient by first administering EMA/CO (Etoposide, methotrexate, actinomycin D/cyclophosphamide, vincristine) chemotherapy and then performing an open uterine surgery to remove residual tumor. The patient who attempted primary chemotherapy for PSTT must be undergone a hysterectomy because this conservative regimen showed sign of chemoresistance. We report a case of chemoresistant PSTT with trial to preserve fertility with a brief review of literatures.
Dactinomycin ; Drug Therapy ; Fertility ; Humans ; Hysterectomy ; Methotrexate ; Neoplasm, Residual ; Trophoblastic Neoplasms ; Trophoblastic Tumor, Placental Site*

BACKGROUND: Rapid on-site evaluation (ROSE) is a technique used for simultaneous evaluation of biopsy specimens through rapid cytology staining. Diff-Quik (DQ) staining is the most commonly employed method for cytological rapid on-site evaluation (C-ROSE). However, the utilization of DQ staining for on-site cytological interpretation remains uncommon among pathologists in China, posing challenges to the implementation of C-ROSE. This study aims to assess the application of rapid hematoxylin-eosin (HE) staining and DQ staining for C-ROSE during percutaneous needle biopsy of peripheral lung cancer and evaluate the value of rapid HE staining in C-ROSE. METHODS: Computed tomography (CT)-guided lung biopsies were conducted on 300 patients diagnosed with peripheral lung cancer. The patients were randomly assigned to two groups for C-ROSE using either rapid HE staining or DQ staining, and subsequently the two methods were compared and evaluated. RESULTS: The concordance rate between C-ROSE and histopathological diagnosis was 96.7%. The median staining time for rapid HE staining was 160 s, while that for DQ staining was 120 s, representing a significant difference between the two groups (P<0.001). However, there were no significant differences observed in terms of total biopsy time, concordance rate with histopathology, cytology specimen peeling rate, and incidence of serious adverse reactions between the two groups (P>0.05). CONCLUSIONS Both staining methods comply with C-ROSE criteria in the biopsy setting of peripheral lung cancer. Rapid HE staining is more aligned with domestic clinical requirements and holds potential for further promotion and adoption in C-ROSE.
Humans ; Lung Neoplasms/pathology* ; Eosine Yellowish-(YS) ; Rapid On-site Evaluation ; Biopsy, Needle/methods* ; Staining and Labeling

Epithelioid trophoblastic tumor (ETT) is an unusual variant of gestational trophoblastic tumor that is closely related to choriocarcinoma and placental site trophoblastic tumor (PSTT) but shows different morphologic, immunohistochemical features. ETT grows in a nodular pattern compared with the infiltrative pattern of PSTT. Histologically the tumor is characterized by uniform population of mononucleate intermediate trophoblastic cells that resemble the trophoblastic cells in the chorionic laeve, so we called them "chorionic-type intermediate trophoblast". Immunohistochemically ETT was positive for cytokeratin, epithelial membrane antigen(EMA) and staining for human placental lactogen (hPL) and human chorionic gonadotrophin (hCG) was generally patchy, focal or negative whereas PSTT contained more hPL-positive cells than hCG-positive cells. ETT can behave in a malignant fashion such as distant metastasis. We experienced a case of ETT by clinical result, pathologic finding, so we report a case with brief literature review.
Choriocarcinoma ; Chorion ; Female ; Humans ; Keratins ; Membranes ; Neoplasm Metastasis ; Placental Lactogen ; Pregnancy ; Trophoblastic Neoplasms* ; Trophoblastic Tumor, Placental Site ; Trophoblasts*

Epithelioid trophoblastic tumor (ETT) is a very rare variant of gestational trophoblastic disease (GTD) which arises in reproductive age women with prior gestational history. Although abnormal vaginal bleeding is the most common symptom of ETT, there are no reported pathognomonic symptoms of ETT because of its rarity. ETT is similar to placental site trophoblastic tumor in terms of its slow growing characteristic and microscopic findings. Therefore, it could be misdiagnosed as placental site trophoblastic tumor or other types of GTD. Unlike other types of GTD, primary treatment of ETT is surgical resection because of its chemo-resistant nature. Accordingly, immunohistochemical staining is essential for accurate diagnosis and appropriate treatment. Here, we report a case of a 42-year-old hysterectomized woman with pelvic masses who suffered from abdominal pain. Through laparotomy, tumors were resected completely and they were diagnosed as ETT through immunohistochemical stain. This report provides more evidence about its clinical features, diagnosis, and treatment including a brief review of the literature.
Abdominal Pain ; Adult ; Diagnosis ; Female ; Gestational Trophoblastic Disease ; Humans ; Laparotomy ; Trophoblastic Neoplasms* ; Trophoblastic Tumor, Placental Site ; Trophoblasts* ; Uterine Hemorrhage

Placntal site trophoblastic tumor (PSTT) has been demonstrated to be a rare form of gestational trophoblastic tumor (GTT). Kurman (1976) et al recognized this disease as Trophoblastic pseudotumor and they thought it to be a benign exaggerated placental site reaction, but Twiggs et al (1981) reported a patient who died of widespread metastasis. Death has been reported in 2 of 14 cases due to metastatic disease, and therefore it is thought to have a malignant course and metastatic potential. It may occur at any age during the reproductive age but usually occurs in relation to second or subsequent pregnancies (a normal pregnancy, an abortion, or a molar pregnancy) rather than primipara. PSTT can metastasis to the brain, lung, liver, vagina and bladder. Larsen et al (1991) report metastasis rate about 10%. It produces little hCG and larger quantities of hPL. We experienced a case of PSTT after normal delivery, which was diagnosed and operated on in our hospital, and report this case with a brief review of literatures.
Brain ; Humans ; Liver ; Lung ; Molar ; Neoplasm Metastasis ; Pregnancy ; Trophoblastic Neoplasms ; Trophoblastic Tumor, Placental Site* ; Trophoblasts ; Urinary Bladder ; Vagina

Post-therapy whole body imaging with I-131 is not routinely done in the Philippines. This added cast of this procedure limits its diagnostic value for those patients who cannot afford it. This study was undertaken to evaluate the diagnostic relevance of I-131 whole body scan following therapeutic doses and its implication in further treatment and follow-up. This study included 61 patients treated in our institutions during a three-year period. Comparison of their-pre- and post-therapy who body scans was done. There were 10 males (16%) and 51 (84%) females with a mean age of 45 years + 15 (range, 17-77). Thirty three patients (54%) have corresponding pre-therapy serum thyroglobulin determination, which also guided the clinicians in the administration of appropriate therapeutic doses. The post-therapy studies were performed prior to hospital discharge . The mean interval between administration of therapy dose and imaging was 4 days (range, 2-10 days). About 34 patients (56% did not have any significant change between their pre- and post-therapy whole body scans. In 27 cases (44%), additional findings indicative of local and/or distant thyroid cancer metastasis were noted. Unsuspected cervical nodes were appreciated in 15(24%) of these cases. Seven (7) cases (11%) presented with increased metastatic deposits in the affected area. New areas of metastases were evident in 5 cases (8%). Our present data suggests that the incorporation of post-therapy whole body scans in the clinical evaluation of patients with well-differentiated thyroid cancer may help in the optimum therapeutic management and future follow-up of patients.
Human ; Male ; Female ; Middle Aged ; WHOLE BODY IMAGING ; DIAGNOSIS ; DIAGNOSTIC TECHNIQUES AND PROCEDURES ; DIAGNOSTIC IMAGING ; THYROID NEOPLASMS ; NEOPLASMS ; NEOPLASMS BY SITE ; ENDOCRINE GLAND NEOPLASMS

OBJECTIVEIn order to get better understanding of placental site trophoblastic tumor (PSTT), we have investigated 4 PSTT cases that diagnosed in our hospital and with literature reviews.

METHODSWe identified 4 patients of PSTT in our choriocarcinoma ward from Jan, 1985 to Dec, 2000 by retrospective analysis.

RESULTSPSTT accounted for 3.1@1000 of all trophoblastic diseases, the ratio of PSTT to choriocarcinoma was 1:138. The average age was 31. Two cases were secondary to hydatidiform mole with paremetrial or pulmonary metastasis respectively. All cases received hysterectomy and multiple chemotherapy. With a follow-up of 29 to 84 months, all patients are survived up to now.

CONCLUSIONSPSTT is a rare gestational trophoblastic tumor. Accurate pathological diagnosis is critical for proper treatment. The diagnosis and monitor are rather difficult because the beta-hCG are non-parallel to the growth and disappearance of the tumor. Operation plays an important role in its treatment, and multiple chemotherapy is helpful.

Adult ; Chorionic Gonadotropin, beta Subunit, Human ; blood ; Female ; Follow-Up Studies ; Humans ; Pregnancy ; Retrospective Studies ; Trophoblastic Tumor, Placental Site ; diagnosis ; surgery ; Uterine Neoplasms ; diagnosis ; surgery